Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messaging, and novel approaches in antiviral treatment.